Urology
Volume 74, Issue 4 , Pages 731-734 , October 2009

Focal Therapy for Prostate Cancer Is a Reasonable Treatment Option in Properly Selected Patients: Oppose

  • Nelson N. Stone

      Affiliations

    • Corresponding Author InformationReprint requests: Nelson N. Stone, M.D., 21 Timber Trail, Suffern, NY 10901

Received 15 April 2009 ,Accepted 8 May 2009.

References 

  1. Andriole GL, Grubb RL, Buys SS, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310–1319
  2. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320–1328
  3. Eggener SE, Mueller A, Berglund RK, et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol. 2009;181:1635–1641
  4. Meiers I, Waters DJ, Bostwick DG. Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007. Urology. 2007;70(suppl 6A):3–8
  5. Polascik TJ, Mayes JM, Schroeck FR, et al. Patient selection for hemiablative focal therapy of prostate cancer. Cancer. 2009;115:2104–2110
  6. Tareen B, Godoy G, Sankin A, et al. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int., in press.
  7. Tareen B, Sankin A, Godoy G, et al. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in a contemporary cohort. Urology. 2009;73:351–354
  8. Schulte RT, Wood DP, Daignault S, et al. Utility of extended pattern prostate biopsies for tumor localization. Cancer. 2008;113:1559–1565
  9. Andriole GL, Bullock TL, Belani JS, et al. Is there a better way to biopsy the prostate? (Prospects for a novel transrectal systematic biopsy approach). Urology. 2007;70(suppl 6A):22–26
  10. Onik G, Bazell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal cancer therapy. Urol Oncol. 2008;26:506–510
  11. Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate—a 4-year experience. Urology. 2007;70(suppl 6A):27–35
  12. Li H, Yan W, Zhou Y, et al. Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases. Urology. 2007;70:1157–1161
  13. Merrick GS, Gutman S, Andreini H, et al. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur Urol. 2007;52:715–724
  14. Moran BJ, Braccioforte MH, Conterato DJ. Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol. 2006;176:1376–1381
  15. Wise AM, Stamey TA, McNeal JE, et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002;60:264–269
  16. Cupp MR, Bostwick DG, Myers RP, et al. The volume prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol. 1995;153:1543–1548
  17. Ravery V, Schmid HP, Toublanc M, et al. Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma?. Cancer. 1996;78:1079–1084
  18. Scales CD, Presti JC, Kane CJ, et al. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy-results from the SEARCH database. J Urol. 2007;178:1249–1252
  19. Onik G, Vaughn D, Lotenfoe R, et al. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26:500–505
  20. Santiago RJ, Wu L, Harris E, et al. 15-year results of breast conserving surgery and definitive irradiation for stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 2004;58:233–240
  21. Banh DK, Silverman P, Lee F, et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006;20:688–692
  22. Lambert EH, Bolte K, Masson P, et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007;69:1117–1120
  23. Marberger M, Carroll PR, Zelefsky MJ, et al. New treatments for localized prostate cancer. Urology. 2008;72(suppl 6A):36–43
  24. Stephenson AJ, Kattan MW, Eastham JA, et al. Prostate cancer specific mortality after radical prostatectomy in the prostate specific antigen era. Paper presented at: The American Society of Clinical Oncology (ASCO), 2008 Genitourinary Symposium; February 15, 2008; San Francisco, California.
  25. Sheridan TB, Carter HB, Wang W, et al. Change in prostate cancer grade over time in men followed expectantly for stage T1c disease. J Urol. 2008;179:901–905
  26. Ahmed HU, Moore C, Emberton M. Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol., in press.
  27. Muto S, Yoshii T, Saito K, et al. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol. 2008;38:192–199
  28. Ward JF, Nakanishi H, Pisters L, et al. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. BJU Int. In press.

 Dr Stone is an owner of Prologics LLC and is a consultant for Nihon-Medi-Physics and IsoAid.

PII: S0090-4295(09)00646-3

doi: 10.1016/j.urology.2009.05.023

Urology
Volume 74, Issue 4 , Pages 731-734 , October 2009

Article Tools